Dr Reddy's announces launch of OTC tablets in US market
Pharma major Dr Reddy's Laboratories today said it has launched its over-the-counter (OTC) Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride extended release tablets in the US market.
Nov 20, 2014, 18:45 PM IST
DRL may file new drug applications with FDA within year
Drug maker Dr Reddy's Laboratories has said it may file two new drug applications (NDA) with the US Food and Drug Authority (FDA) by the end of next year.
Nov 02, 2014, 14:15 PM IST
Dr Reddy's Q2 net down 17% at Rs 574.1 cr
Net income during the period under review stood at Rs 3,587.81 crore as against Rs 3,357.45 crore in the year-ago period, Dr Reddy's Laboratories said in a filing to BSE.
Oct 29, 2014, 16:07 PM IST
NPPA order may not impact much, seeking legal advice: Reddy's
The recent National Pharmaceutical Pricing Authority (NPPA) order bringing in some more medicines under control may not have much impact on city-based drug maker Dr Reddy's Laboratories in terms of product pricing, according to a senior company official.
Jul 16, 2014, 16:25 PM IST
